Comcast doesn't just see paid fast lanes being useful for medicine, however. It also thinks they might be fair to sell to automakers for use in autonomous vehicles. "Likewise, for autonomous vehicles that may require instantaneous data transmission, black letter prohibitions on paid prioritization may actually stifle innovation instead of encouraging it," the filing says. This makes Comcast's position pretty confusing. Comcast says it opposes prioritizing one website over another. It even suggests the commission adopt a "strong presumption against" agreements that benefit an ISP's own content over competitors' work, but it's not clear how benefiting one car company or telemedicine company over another is any different.
The second study -- the largest of its kind -- involved more than 450,000 participants, recruited between 1992 and 2000 across ten European countries, who were again followed for just over 16 years on average. After a range of factors including age, smoking status, physical activity and education were taken into account, those who drank three or more cups a day were found to have a 18% lower risk of death for men, and a 8% lower risk of death for women at any age, compared with those who didn't drink the brew. The benefits were found to hold regardless of the country, although coffee drinking was not linked to a lower risk of death for all types of cancer. The study also looked at a subset of 14,800 participants, finding that coffee-drinkers had better results on many biological markers including liver enzymes and glucose control. But experts warn that the two studies, both published in the Annals of Internal Medicine, do not show that drinking coffee was behind the overall lower risk, pointing out that it could be that coffee drinkers are healthier in various ways or that those who are unwell drink less coffee.
The Washington Post notes that acetaminophen is the most common drug ingredient in the United States, adding that "about a quarter of all Americans take acetaminophen every week."
But if approved, it would be the largest data breach settlement in history, according to the plaintiffs' lawyers, who announced the agreement Friday. The funds would be used to provide victims of the data breach at least two years of credit monitoring and to reimburse customers for breach-related expenses. The settlement would also guarantee a certain level of funding for "information security to implement or maintain numerous specific changes to its data security systems, including encryption of certain information and archiving sensitive data with strict access controls," the plaintiff attorneys said.
The breach compromised data for 80 million people, including their social security numbers, birthdays, street addresses (and email addresses) as well as income data. The $115 million settlement averages out to $1.43 for every person who was affected.
Venezuela's currency has become nearly worthless in the black market, where it takes more than 6,000 bolivars to buy $1, while bitcoin surged 53 percent in the past month alone. But it's not just about shielding against the falling bolivar, as some Venezuelans are using crypto currencies to buy and sell everyday goods and services, according to Jorge Farias, the CEO of Cryptobuyer.
The report released to members of both the U.S. Senate and House of Representatives on Friday concludes that the U.S. healthcare system is plagued by weaknesses, from the leadership and governance of information security within healthcare organizations, to the security of medical devices and medical laboratories to hiring and user awareness. Many of the risks directly affect patient safety, the group found. It comes amid growing threats to healthcare organizations, including a ransomware outbreak that affected scores of hospitals in the United Kingdom.
Joshua Corman, the Director of the Cyber Statecraft Initiative at The Atlantic Council, argues that currently "Healthcare is target rich and resource poor," adding a special warning about the heavy usage of internet-connected healthcare equipment. "If you can't afford to protect it, you can't afford to connect it."
The researchers say that just in the U.S. there are 60,000 new patients every year who could benefit from the new drug.
An Australian news site points out that career-minded researchers pay up to $3,000 to get their work published in predatory journals so they can list more publications on their resumes. "While this started as something lighthearted," says the dog-owning professor, "I think it is important to expose shams of this kind which prey on the gullible, especially young or naive academics and those from developing countries."